Nandrolone decanoate is an androgen and anabolic steroid (AAS) drug primarily used for the treatment of anemia and wasting syndromes as well as osteoporosis in menopausal women. It is given by injection into muscle or fat every one to four weeks. Nandrolone decanoate is slowly released from the injection site into the blood, with a half-life of 6 days.
Nandrolone phenylpropionate (NPP) or nandrolone fenpropionate, sold under the brand name Durabolin among others, is an androgen and anabolic steroid (AAS) drug primarily used in the treatment of breast cancer and osteoporosis in women. It is given by intramuscular injection once a week.
NPP is converted to nandrolone in the body, which is the active form of the drug. It has a long elimination half-life in the body when administered by intramuscular injection. The duration of action is about a week and is applied every few days to once a week. The elimination half-life and duration of action of NPP is much shorter than that of nandrolone decanoate.
Oxymetholone is an androgen and anabolic steroid (AAS) medication which is used primarily in the treatment of anemia. It is also used to treat osteoporosis, HIV/AIDS wasting syndrome, and to promote weight gain and muscle growth in certain situations. It is taken by mouth.
Clenoxin is a compound that belongs to a class of drugs called beta2-agonists. Beta2-agonists are often used to treat asthma.
Unless recommended otherwise by doctors, the recommended dose is consumed with a glass of water per day according to body weight ratio. Generally, the effective dose is 1-2 mg per body weight per day. The dose of use should be regulated with the advice of a doctor.
The usage period may vary between three and six months, depending on the person's health status.
Fluoxymesterone is an androgen and anabolic steroid (AAS) medication which is used in the treatment of low testosterone levels in men, delayed puberty in boys, breast cancer in women, and anemia. It is taken by mouth.
Side effects of fluoxymesterone include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. It can also cause liver damage and cardiovascular side effects like high blood pressure. The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has strong androgenic effects and moderate anabolic effects, which make it useful for producing masculinization.
Drostanolone enanthate is an androgen and anabolic steroid (AAS) drug used to treat breast cancer in women but is no longer marketed. It is given by intramuscular injection.
Drostanolone enanthate is not orally active and must be administered by intramuscular injection. The elimination half-life of the drug by this route is approximately 8 days. It has a much longer elimination half-life by intramuscular injection than drostanolone. Drostanolone propionate is metabolized to the active form, drostanolone.
Trenbolone hexahydrobenzylcarbonate or trenbolone cyclohexylmethylcarbonate is a synthetic injectable anabolic-androgenic steroid (AAS) of the nandrolone group and an androgen ester – specifically the C17β hexahydrobenzylcarbonate (cyclohexylmethylcarbonate) ester of trenbolone.
Trenbolone hexahydrobenzylcarbonate has an activated elimination half-life of about 14 days, of about 14 days.
Trenbolone enanthate is a synthetic and injected anabolic-androgenic steroid and a derivative of nandrolone that was never marketed. It is the C17β enanthate ester and a long-acting trenbolone prodrug.
This ester gives trenbolone an active elimination half-life of approximately 8 days.